Acorah Software Products - Accounts Production14.6.300falsetruefalsetrueNo description of principal activity19 January 202331 January 202431 January 202414605419Mrs Jasmeet Jhootiiso4217:GBPiso4217:EURiso4217:USDxbrli:sharesxbrli:purexbrli:pure146054192023-01-18146054192024-01-31146054192023-01-192024-01-3114605419frs-core:CurrentFinancialInstruments2024-01-3114605419frs-bus:PrivateLimitedCompanyLtd2023-01-192024-01-3114605419frs-bus:FilletedAccounts2023-01-192024-01-3114605419frs-bus:Micro-entities2023-01-192024-01-3114605419frs-bus:AuditExempt-NoAccountantsReport2023-01-192024-01-3114605419frs-bus:Director12023-01-192024-01-31
Registered number: 14605419
Derma Lab London Limited
Unaudited Financial Statements
For the Period 19 January 2023 to 31 January 2024
Derma Lab London Limited
Balance Sheet
As At 31 January 2024
Balance Sheet
Registered number: 14605419
31 January 2024
£
Fixed assets
18,860
Current assets
10,187
Creditors: Amounts Falling Due Within One Year
(24,070)
NET CURRENT LIABILITIES
(13,883)
TOTAL ASSETS LESS CURRENT LIABILITIES
4,977
NET ASSETS
4,977
CAPITAL AND RESERVES
4,977
Notes
1.General Information
Derma Lab London Limited is a private company, limited by shares, incorporated in England & Wales, registered number 14605419. The registered office is 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ.
2.Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
For the period ending 31 January 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.